News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ESMO: New Agent Active in Advanced Ovarian Cancer, Dana-Farber Cancer Institute Study


10/15/2010 6:40:33 AM

MedPageToday -- MILAN -- A quarter of patients with platinum-refractory or resistant ovarian cancer had a good response to an investigational agent that targets a kinase implicated in oncogenesis and tumor progression, results from a small preliminary clinical trial showed.

Read at MedPageToday
Read at ScienceBlog
Read at Medical News Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES